363 related articles for article (PubMed ID: 31882677)
1. Characterization of a five-microRNA signature as a prognostic biomarker for esophageal squamous cell carcinoma.
Yu J; Zhu M; Lv M; Wu X; Zhang X; Zhang Y; Li J; Zhang Q
Sci Rep; 2019 Dec; 9(1):19847. PubMed ID: 31882677
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA expression in esophageal squamous cell carcinoma: Novel diagnostic and prognostic biomarkers.
Wang Y; Zhang J; Zhao W; Wang D; Ma W; Shang S; Feng C; Yu H
Mol Med Rep; 2017 Jun; 15(6):3833-3839. PubMed ID: 28440443
[TBL] [Abstract][Full Text] [Related]
3. A six-microRNA risk score model predicts prognosis in esophageal squamous cell carcinoma.
Mao Y; Fu Z; Zhang Y; Dong L; Zhang Y; Zhang Q; Li X; Wang C
J Cell Physiol; 2019 May; 234(5):6810-6819. PubMed ID: 30387125
[TBL] [Abstract][Full Text] [Related]
4. A novel serum microRNA signature to screen esophageal squamous cell carcinoma.
Huang Z; Zhang L; Zhu D; Shan X; Zhou X; Qi LW; Wu L; Zhu J; Cheng W; Zhang H; Chen Y; Zhu W; Wang T; Liu P
Cancer Med; 2017 Jan; 6(1):109-119. PubMed ID: 28035762
[TBL] [Abstract][Full Text] [Related]
5. Construction and validation of a three-microRNA signature as prognostic biomarker in patients with hepatocellular carcinoma.
Zhang X; Ma L; Zhai L; Chen D; Li Y; Shang Z; Zhang Z; Gao Y; Yang W; Li Y; Pan Y
Int J Med Sci; 2021; 18(4):984-999. PubMed ID: 33456356
[TBL] [Abstract][Full Text] [Related]
6. Identification of prognostic miRNA biomarkers for esophageal cancer based on The Cancer Genome Atlas and Gene Expression Omnibus.
Xue J; Jia E; Ren N; Xin H
Medicine (Baltimore); 2021 Feb; 100(7):e24832. PubMed ID: 33607850
[TBL] [Abstract][Full Text] [Related]
7. Identification of microRNAs as novel biomarkers for esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas (TCGA) and bioinformatics.
Li CY; Zhang WW; Xiang JL; Wang XH; Li J; Wang JL
Chin Med J (Engl); 2019 Sep; 132(18):2213-2222. PubMed ID: 31490264
[TBL] [Abstract][Full Text] [Related]
8. A six-microRNA signature in plasma was identified as a potential biomarker in diagnosis of esophageal squamous cell carcinoma.
Zhou X; Wen W; Zhu J; Huang Z; Zhang L; Zhang H; Qi LW; Shan X; Wang T; Cheng W; Zhu D; Yin Y; Chen Y; Zhu W; Shu Y; Liu P
Oncotarget; 2017 May; 8(21):34468-34480. PubMed ID: 28380431
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic and prognostic implications of a serum miRNA panel in oesophageal squamous cell carcinoma.
Wu C; Wang C; Guan X; Liu Y; Li D; Zhou X; Zhang Y; Chen X; Wang J; Zen K; Zhang CY; Zhang C
PLoS One; 2014; 9(3):e92292. PubMed ID: 24651474
[TBL] [Abstract][Full Text] [Related]
10. A three-lncRNA signature predicts overall survival and disease-free survival in patients with esophageal squamous cell carcinoma.
Huang GW; Xue YJ; Wu ZY; Xu XE; Wu JY; Cao HH; Zhu Y; He JZ; Li CQ; Li EM; Xu LY
BMC Cancer; 2018 Feb; 18(1):147. PubMed ID: 29409459
[TBL] [Abstract][Full Text] [Related]
11. Identification of a seven-miRNA signature as prognostic biomarker for lung squamous cell carcinoma.
Gao X; Wu Y; Yu W; Li H
Oncotarget; 2016 Dec; 7(49):81670-81679. PubMed ID: 27835574
[TBL] [Abstract][Full Text] [Related]
12. Bioinformatics identification of lncRNA biomarkers associated with the progression of esophageal squamous cell carcinoma.
Yu J; Wu X; Huang K; Zhu M; Zhang X; Zhang Y; Chen S; Xu X; Zhang Q
Mol Med Rep; 2019 Jun; 19(6):5309-5320. PubMed ID: 31059058
[TBL] [Abstract][Full Text] [Related]
13. MiR-613: a novel diagnostic and prognostic biomarker for patients with esophageal squamous cell carcinoma.
Guan S; Wang C; Chen X; Liu B; Tan B; Liu F; Wang D; Han L; Wang L; Huang X; Wang J; Yao B; Shi J; Chen P; Nesa EU; Song Q; Cheng Y
Tumour Biol; 2016 Apr; 37(4):4383-91. PubMed ID: 26499784
[TBL] [Abstract][Full Text] [Related]
14. A three-gene signature from protein-protein interaction network of LOXL2- and actin-related proteins for esophageal squamous cell carcinoma prognosis.
Zhan XH; Jiao JW; Zhang HF; Li CQ; Zhao JM; Liao LD; Wu JY; Wu BL; Wu ZY; Wang SH; Du ZP; Shen JH; Zou HY; Neufeld G; Xu LY; Li EM
Cancer Med; 2017 Jul; 6(7):1707-1719. PubMed ID: 28556501
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis.
Liu N; Chen NY; Cui RX; Li WF; Li Y; Wei RR; Zhang MY; Sun Y; Huang BJ; Chen M; He QM; Jiang N; Chen L; Cho WC; Yun JP; Zeng J; Liu LZ; Li L; Guo Y; Wang HY; Ma J
Lancet Oncol; 2012 Jun; 13(6):633-41. PubMed ID: 22560814
[TBL] [Abstract][Full Text] [Related]
16. Identification of a nomogram based on long non-coding RNA to improve prognosis prediction of esophageal squamous cell carcinoma.
Li W; Liu J; Zhao H
Aging (Albany NY); 2020 Jan; 12(2):1512-1526. PubMed ID: 31978896
[TBL] [Abstract][Full Text] [Related]
17. A four-miRNA signature as a novel biomarker for predicting survival in endometrial cancer.
Wu YS; Lin H; Chen D; Yi Z; Zeng B; Jiang Y; Ren G
Gene; 2019 May; 697():86-93. PubMed ID: 30779946
[TBL] [Abstract][Full Text] [Related]
18. Identification of a six microRNA signature as a novel potential prognostic biomarker in patients with head and neck squamous cell carcinoma.
Shi H; Chen J; Li Y; Li G; Zhong R; Du D; Meng R; Kong W; Lu M
Oncotarget; 2016 Apr; 7(16):21579-90. PubMed ID: 26933913
[TBL] [Abstract][Full Text] [Related]
19. A 10‑microRNA prognosis scoring system in esophageal squamous cell carcinoma constructed using bioinformatic methods.
Sun Q; Zong L; Zhang H; Deng Y; Zhang C; Zhang L
Mol Med Rep; 2018 Apr; 17(4):5222-5228. PubMed ID: 29393486
[TBL] [Abstract][Full Text] [Related]
20. Plasma miRNA-506 as a Prognostic Biomarker for Esophageal Squamous Cell Carcinoma.
Li SP; Su HX; Zhao D; Guan QL
Med Sci Monit; 2016 Jun; 22():2195-201. PubMed ID: 27345473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
